我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
1 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
尚未招募
100.0%
暂无批准数据
- NEOM has signed a strategic memorandum of understanding with WuXi AppTec to explore localization of pharmaceutical research, development and manufacturing capabilities in Saudi Arabia. - The partnership aims to create world-class CRDMO facilities at Oxagon, NEOM's advanced manufacturing city, supporting Saudi Arabia's economic diversification and biotechnology ambitions. - This collaboration represents a significant step forward in advancing the Kingdom's National Biotech Strategy as part of Saudi Vision 2030. - The agreement leverages WuXi AppTec's decades of biopharmaceutical innovation experience with NEOM's state-of-the-art clean manufacturing infrastructure to serve regional and global markets.
